Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_65b5f7aa8cd0f81320dd1a5f30dbb6af http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33280a73e40dc09e7627e92ece14dc50 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16222 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10321 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10322 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10343 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10332 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-525 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-861 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-28 |
filingDate |
2007-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5076beeae8abb5e5b04a0e65c3e98b71 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd4b84ab49dc2a2d0b7107ba8e2981db |
publicationDate |
2007-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2007298464-A1 |
titleOfInvention |
Methods of producing erythropoietin isoforms comprising Lewis-X structures and high sialic acid content and compositions of the same |
abstract |
Disclosed are immortalized human embryonic retina cells, having a nucleic acid sequence encoding an adenoviral E1A protein integrated into the genome of the cells, and further comprising a nucleic acid sequence encoding an enzyme involved in post-translational modification of proteins, such as a sialyltransferase, wherein the nucleic acid sequence encoding the enzyme involved in post-translational modification of proteins is under control of a heterologous promoter. Methods for producing recombinant proteins from such cells and obtaining such recombinant proteins having increased sialylation are provided as are novel compositions of isoforms of erythropoietin. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8802417-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009324645-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8404226-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7767643-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009239287-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008050403-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7964198-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7833788-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005164386-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007231860-A1 |
priorityDate |
1999-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |